Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Status:
Recruiting

Trial end date:
2021-08-31

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety of XAV-19 drug in patients with moderate-to-severe COVID-19.

Phase 2/Phase 3

Xenothera SAS